Applications and Advances of Omics and Bioinformatics in the Research of Alzheimer’s Disease and Complex Phenotypes
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Bioinformatics and Systems Biology".
Deadline for manuscript submissions: closed (20 August 2023) | Viewed by 6667
Special Issue Editor
Interests: Alzheimer's association; bioinformatics; genetics; genomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Late-onset Alzheimer’s disease is a complex trait that is challenging to diagnose, nearly impossible to predict before the onset of symptoms and has no effective treatments. As a multi-faceted trait, the solutions will likely require innovation from many different areas of disease research. One challenge we seek to address here is solving the genetic architecture of complex traits. Significant efforts have been made to understand the genetics of Alzheimer’s disease. However, although estimates vary, we still cannot explain most of the heritability of Alzheimer’s disease with known genetic risk factors. Large sequencing projects exist and are underway (e.g., the Alzheimer’s Disease Sequencing Project), and datasets are being expanded to include transcriptomes, proteomes, metabolomes, etc. Although we specifically described Alzheimer’s disease here, similar datasets and challenges exist for many diseases, and computational advances are likely to be widely applicable. We seek manuscripts that describe novel methods for interrogating any or all omics data to find disease markers or provide insights into disease processes, or the application of computational approaches to research Alzheimer’s disease or other complex traits.
Dr. Perry G. Ridge
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioinformatics
- genomics
- Alzheimer’s disease
- complex phenotypes
- multi-omics
- methods